FDA NDC Directory · JSON-LD · Markdown

LYTENAVA

NDC 82491-025 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic namebevacizumab-vikg
Labeler / ManufacturerOutlook Therapeutics, Inc.
Marketing categoryBiologic License Application · App BLA761320
Dosage form / routeINJECTION · INTRAVITREAL
Active ingredientsBEVACIZUMAB (1.25 mg/1)
Marketing started20260716
Package count1

External sources

Source: openFDA. Public-domain (CC0).